2024 What's Next for US Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hema

2024 What's Next for US Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 tests within the following market segments:

Blood Banking
Cancer
Chemistry
Coagulation
Drugs of Abuse
Endocrine
Hematology and Flow Cytometry
Immunoprotein
Infectious Diseases
Molecular Diagnostics
TDM

The report profiles over 70 companies, including:

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Cepheid/Danaher
Becton Dickinson
Bio/Data
Biokit
bioMerieux
Bio-Rad
CellaVision
Chrono-Log
Corgenix
Decode Genetics
Diagnostica Stago
Diamedix
DiaSorin
Diazyme
Eiken Chemical
EKF Diagnostics
Elitech Group
Enzo Biochem
Epigenomics
Erba Mannheim
Exact Sciences
Fujifilm Wako
Fujirebio
Grifols
Guided Therapeutics
Helena Laboratories
Hologic
Horiba
HYPHEN BioMed
Illumina
Immucor
Instrumentation Laboratory/Werfen
Kyowa Medex
Leica Biosystems
Li-Cor Biosciences
Lonza
Mindray
Myriad Genetics
Nexus Dx
Nihon Kohden
OncoLab
PerkinElmer
Polymedco
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Scienion
Sekisui Diagnostics
SeraCare
Shimadzu
Siemens Healthineers
Sienco
Sierra Molecular
Sysmex
Takara Bio
Tecan
Thermo Fisher
Tosoh

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.